Ning Liu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Circular RNAs in diseases
- Ubiquitin and proteasome pathways
Papers in
-
- MicroRNA in disease regulation 10
- Immunology 25
Ning Liu
174 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 153
- Cancer Research 494
- Molecular Biology 1.3k
- Rehabilitation 110
- Cell Biology 248
- Oncology 413
Countries citing papers authored by Ning Liu
This map shows the geographic impact of Ning Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Liu more than expected).
Fields of papers citing papers by Ning Liu
This network shows the impact of papers produced by Ning Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Liu. The network helps show where Ning Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 38 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 40 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 3 | |
| 11 | Pan-Cancer Transcriptomic Analysis Identifies PLK1 Crucial for the Tumorigenesis of Clear Cell Renal Cell Carcinoma | 2022 | 4 |
| 12 | 2021 | 9 | |
| 13 | 2020 | 4 | |
| 14 | 2019 | 17 | |
| 15 | 2019 | 19 | |
| 16 | 2017 | 152 | |
| 17 | 2016 | 6 | |
| 18 | 2015 | 1 | |
| 19 | Determination of total content of reducing saccharide in dry powder of Maranta arundinacea L.by spectrophotomertry | 2013 | 1 |
| 20 | 2011 | 1 |
About Ning Liu
Ning Liu is a scholar working on Cancer Research, Immunology, Oncology, Molecular Medicine and Cell Biology, having authored 189 papers that have together received 3.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (7 papers), Epigenetics and DNA Methylation (7 papers), Cancer Cells and Metastasis (7 papers), Cancer Mechanisms and Therapy (6 papers), Ubiquitin and proteasome pathways (6 papers), Histone Deacetylase Inhibitors Research (5 papers) and Autophagy in Disease and Therapy (5 papers). The work is most often cited by research in Cancer Research (494 citations), Molecular Biology (1.3k citations), Rehabilitation (110 citations), Cell Biology (248 citations) and Oncology (413 citations). Ning Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Mingxing Ma, Gerald T. Miwa, Cindy Q. Xia, Liang‐Shang Gan, Yueliang Zhao, Na Yang, Cong Yu, Ming Zhu, Yamin Zhu and Mingfu Wang. Their work appears in journals such as International Immunopharmacology, Biomedicine & Pharmacotherapy, European Journal of Medicinal Chemistry, Scientific Reports and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.